Bioblast Pharma Ltd. (ORPN) dipped -6.37% or -0.17 to $2.5. It is near 97087 shares traded, which is 27.75% compare to the average total volume 349834. The market cap of ORPN is $8.36 million. The year to date change is 20.27%. The 52 week price range is from $1.49 to $7.75. Price of ORPN have changed 5.95% during last week. It have changed 34.85% over last month, 11.25% over last 3 months, -16.56% over last 6 months and -53.16% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ORPN is 2.21. It is -11.60% below current price. The 200-day Moving Averages for ORPN is 2.58. It is 3.20% above current price. The 52-week High is 7.75. It is 210.00% from the current price. The 52-week Low is 1.49. It is -40.40% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of ORPN is 0.94 on 2017-12-29. Short % to float is 3.55%. There are some statistics of ORPN. It is has market cap $8.36 million. The share outstanding is 3.34 million. The average volume is 349834. The percent of top 15 Institution holding is 4.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ORPN is -111.78%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ORPN is -95.72%.